These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 20693773)

  • 21. Genetic landscape of RASopathies in Chinese: Three decades' experience in Hong Kong.
    Yu KPT; Luk HM; Leung GKC; Mak CCY; Cheng SSW; Hau EWL; Chan DKH; Lam STS; Tong TMF; Chung BHY; Lo IFM
    Am J Med Genet C Semin Med Genet; 2019 Jun; 181(2):208-217. PubMed ID: 30896080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neonatal atrial tachycardia: suggestive clinical sign of Costello syndrome].
    Laux D; Bajolle F; Maltret A; Bonnet D
    Arch Pediatr; 2011 Oct; 18(10):1087-9. PubMed ID: 21885263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac manifestations and gene mutations of patients with RASopathies in Taiwan.
    Lee CL; Tan LTH; Lin HY; Hwu WL; Lee NC; Chien YH; Chuang CK; Wu MH; Wang JK; Chu SY; Lin JL; Lo FS; Su PH; Hsu CC; Ko YY; Chen MR; Chiu HC; Lin SP
    Am J Med Genet A; 2020 Feb; 182(2):357-364. PubMed ID: 31837205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation.
    Araki T; Mohi MG; Ismat FA; Bronson RT; Williams IR; Kutok JL; Yang W; Pao LI; Gilliland DG; Epstein JA; Neel BG
    Nat Med; 2004 Aug; 10(8):849-57. PubMed ID: 15273746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone resorption in syndromes of the Ras/MAPK pathway.
    Stevenson DA; Schwarz EL; Carey JC; Viskochil DH; Hanson H; Bauer S; Weng HY; Greene T; Reinker K; Swensen J; Chan RJ; Yang FC; Senbanjo L; Yang Z; Mao R; Pasquali M
    Clin Genet; 2011 Dec; 80(6):566-73. PubMed ID: 21204800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spectrum of cardiac anomalies in Noonan syndrome as a result of mutations in the PTPN11 gene.
    Sznajer Y; Keren B; Baumann C; Pereira S; Alberti C; Elion J; Cavé H; Verloes A
    Pediatrics; 2007 Jun; 119(6):e1325-31. PubMed ID: 17515436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral muscle weakness in RASopathies.
    Stevenson DA; Allen S; Tidyman WE; Carey JC; Viskochil DH; Stevens A; Hanson H; Sheng X; Thompson BA; Okumura MJ; Reinker K; Johnson B; Rauen KA
    Muscle Nerve; 2012 Sep; 46(3):394-9. PubMed ID: 22907230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonreentrant atrial tachycardia occurs independently of hypertrophic cardiomyopathy in RASopathy patients.
    Levin MD; Saitta SC; Gripp KW; Wenger TL; Ganesh J; Kalish JM; Epstein MR; Smith R; Czosek RJ; Ware SM; Goldenberg P; Myers A; Chatfield KC; Gillespie MJ; Zackai EH; Lin AE
    Am J Med Genet A; 2018 Aug; 176(8):1711-1722. PubMed ID: 30055033
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New prospectives on treatment opportunities in RASopathies.
    Gelb BD; Yohe ME; Wolf C; Andelfinger G
    Am J Med Genet C Semin Med Genet; 2022 Dec; 190(4):541-560. PubMed ID: 36533679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatoblastoma in a Noonan syndrome patient with a PTPN11 mutation.
    Yoshida R; Ogata T; Masawa N; Nagai T
    Pediatr Blood Cancer; 2008 Jun; 50(6):1274-6. PubMed ID: 18253957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofibromatosis-Noonan syndrome: case report and clinicopathogenic review of the Neurofibromatosis-Noonan syndrome and RAS-MAPK pathway.
    Reig I; Boixeda P; Fleta B; Morenoc C; Gámez L; Truchuelo M
    Dermatol Online J; 2011 Apr; 17(4):4. PubMed ID: 21549079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distal phalangeal creases--a distinctive dysmorphic feature in disorders of the RAS signalling pathway?
    Ørstavik KH; Tangeraas T; Molven A; Prescott TE
    Eur J Med Genet; 2007; 50(2):155-8. PubMed ID: 17324647
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advancing RAS/RASopathy therapies: An NCI-sponsored intramural and extramural collaboration for the study of RASopathies.
    Gross AM; Frone M; Gripp KW; Gelb BD; Schoyer L; Schill L; Stronach B; Biesecker LG; Esposito D; Hernandez ER; Legius E; Loh ML; Martin S; Morrison DK; Rauen KA; Wolters PL; Zand D; McCormick F; Savage SA; Stewart DR; Widemann BC; Yohe ME
    Am J Med Genet A; 2020 Apr; 182(4):866-876. PubMed ID: 31913576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skeletal muscle pathology in Costello and cardio-facio-cutaneous syndromes: developmental consequences of germline Ras/MAPK activation on myogenesis.
    Tidyman WE; Lee HS; Rauen KA
    Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):104-14. PubMed ID: 21495178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease in Noonan syndrome.
    Pierpont ME; Digilio MC
    Curr Opin Pediatr; 2018 Oct; 30(5):601-608. PubMed ID: 30024444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Noonan-CFC controversy.
    Neri G; Zollino M; Reynolds JF
    Am J Med Genet; 1991 Jun; 39(3):367-70. PubMed ID: 1867292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal growth in noonan syndrome: the challenge of optimal therapy.
    Savage MO; Padidela R; Kirk JM; Malaquias AC; Jorge AA
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():523-8. PubMed ID: 19550387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Germline gain-of-function mutations in SOS1 cause Noonan syndrome.
    Roberts AE; Araki T; Swanson KD; Montgomery KT; Schiripo TA; Joshi VA; Li L; Yassin Y; Tamburino AM; Neel BG; Kucherlapati RS
    Nat Genet; 2007 Jan; 39(1):70-4. PubMed ID: 17143285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma.
    Jongmans MC; Hoogerbrugge PM; Hilkens L; Flucke U; van der Burgt I; Noordam K; Ruiterkamp-Versteeg M; Yntema HG; Nillesen WM; Ligtenberg MJ; van Kessel AG; Kuiper RP; Hoogerbrugge N
    Genes Chromosomes Cancer; 2010 Jul; 49(7):635-41. PubMed ID: 20461756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome.
    Ion A; Tartaglia M; Song X; Kalidas K; van der Burgt I; Shaw AC; Ming JE; Zampino G; Zackai EH; Dean JC; Somer M; Parenti G; Crosby AH; Patton MA; Gelb BD; Jeffery S
    Hum Genet; 2002 Oct; 111(4-5):421-7. PubMed ID: 12384786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.